Crossmark

Protocol to improve quality of life, functionality, and exercise capacity in patients with axillary web syndrome after breast cancer: a randomized clinical trial

Crossref DOI link: https://doi.org/10.1007/s00520-025-09815-w

Published Online: 2025-08-14

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

González-Rubino, Jesús Baltasar

Martín-Valero, Rocío

Vinolo-Gil, María Jesús
Funding

Funding for this research was provided by:

This trial received competitive funding from the Instituto de Investigación e Innovación Biomédica de Cádiz, Fundación Progreso y Salud

Universidad de Málaga
License Information

Text and Data Mining valid from 2025-08-14

Version of Record valid from 2025-08-14
More Information

Article History

Received: 29 March 2025

Accepted: 26 July 2025

First Online: 14 August 2025

Declarations

: Ethical approval.Ethics approval was granted by the Andalusia Ethics Committee (PEIBA code 1909-N1-21, reg. number 171.21).

: None declared. The authors declare no competing interests.

: The study protocol was approved by the Andalusia Ethics Committee.

Document is current

Any future updates will be listed below